USP39 and renal cell carcinoma: Considering that the high expression of USP39 predicted poor prognosis in patients with low TNM stage and TNM stage is currently recognized as an indicator for predicting survival and prognosis of patients with renal cell carcinoma, we hypothesized whether TNM stage combined with USP39 expression could improve the ability to predict prognosis in RCC patients.